(Q37915051)

25 August 2017

1 reference

title

Probiotics in the management of children with allergy and other disorders of intestinal inflammation (English)

1 reference

25 August 2017

0 references

0 references

J A Vanderhoof

1

1 reference

25 August 2017

S H Mitmesser

series ordinal

2

1 reference

25 August 2017

publication date

1 November 2010

1 reference

25 August 2017

1 reference

25 August 2017

volume

1

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

351-356

1 reference

Probiotics for prevention of necrotizing enterocolitis in preterm infants

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

The mechanism of action of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Probiotics in human medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Age of entry to day nursery and allergy in later childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Probiotics: a novel approach in the management of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

The initial care of newborn infants and subsequent hay fever

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Probiotic bacteria and intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Probiotics promote gut health through stimulation of epithelial innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

The hygiene hypothesis of atopic disease--an extended version.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Regulation of the development of type 2 T-helper cells in allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Changing prevalence of allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Effects of probiotics on atopic dermatitis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

Lactobacillus GG Improves Recovery in Infants with Blood in the Stools and Presumptive Allergic Colitis Compared with Extensively Hydrolyzed Formula Alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2010.0034

21 January 2018

Identifiers

DOI

10.3920/BM2010.0034

1 reference

25 August 2017

1 reference